|
06.06.2018 22:01:00
|
Streamline Health® Reports First Quarter 2018 Financial Performance
ATLANTA, June 6, 2018 /PRNewswire/ -- Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of integrated solutions, technology-enabled services and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced financial results for the first quarter of fiscal year 2018, which ended April 30, 2018.
Revenues for the three-month period ended April 30, 2018 were $6.3 million, an increase of approximately 6% as compared to the three-months ended April 30, 2017. Adjusted EBITDA for the first quarter of fiscal 2018 was approximately $0.6 million, a substantial improvement over the $400,000 loss in the first quarter a year ago. Net loss for the first quarter of fiscal 2018 was approximately $569,000, a substantial improvement over the $2.0 million net loss in the same period a year ago.
"Our first quarter performance was very solid as we began to realize the benefits of focusing our selling efforts on solutions in the middle of the revenue cycle to help our clients capture the financial reimbursement they deserve for the patient care they provided. Bookings in the quarter improved significantly to $3.4 million as we sold Abstracting, Clinical Documentation Integrity and eValuator solutions to current and new clients," stated David Sides, President and Chief Executive Officer, Streamline Health. "Our continued focus on tighter cost controls delivered improved bottom line results as well. Total operating expenses decreased by approximately 15 percent as compared to first quarter a year ago reducing operating loss in the quarter to approximately $363,000, down from last year's first quarter operating loss of $1,874,000. And net loss for the first quarter was approximately $569,000, a marked improvement over a $2 million loss in the first quarter of last year."
"We remain committed to leading an industry movement to improve hospitals' financial performance by moving mid-cycle billing interventions upstream - to improve coding accuracy before billing, enabling our clients to reduce lost revenue, mitigate overbill risk, and reduce denials and days in accounts receivable."
Highlights for the first quarter ended April 30, 2018 included:
- Revenues for the first quarter of 2018 were $6.3 million;
- Adjusted EBITDA for the first quarter of 2018 was $0.6 million;
- Net loss for the first quarter of 2018 was $569,000;
- New sales bookings for the first quarter of 2018 were $3.4 million; and
- Backlog at the end of the first quarter was $26.1 million.
The Company is planning to file its Form 10-Q for the first fiscal quarter during the week of June 11th.
The Company also announced the impending departure of its Chief Financial Officer, Nicholas Meeks, who will remain with the Company through June 15, 2018. Mr. Meeks is leaving the Company to pursue another opportunity with another company based in the Atlanta market. The Company is actively seeking his replacement and has begun interviewing potential candidates to fill this position.
Conference Call Information
The Company will conduct a conference call to review the results on Thursday, June 7, 2018 at 9:00 AM ET. Interested parties can access the call by joining the live webcast: click here to register. You can also join by phone by dialing 800-263-0877 and then entering passcode 7132733.
A replay of the conference call will be available from Thursday, June 7, 2018 at 12:00 PM ET to Tuesday, June 12, 2018 at 12:00 PM ET by dialing 888-203-1112 and entering passcode 7132733.
*Non-GAAP Financial Measures
Streamline Health reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). Streamline Health's management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure. Streamline Health's management believes that this measure provides useful supplemental information regarding the performance of Streamline Health's business operations.
Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, and professional and advisory fees. A table reconciling this measure to net income is included in this press release.
About Streamline Health
Streamline Health Solutions, Inc. (NASDAQ: STRM) is a healthcare industry leader in capturing, aggregating, and translating enterprise data into knowledge – producing actionable insights that support revenue cycle optimization for healthcare enterprises. We deliver integrated solutions, technology-enabled services and analytics that empower providers to drive revenue integrity in a value-based world. We share a common calling and commitment to advance the quality of life and the quality of healthcare – for society, our clients, the communities they serve, and the individual patient. For more information, please visit our website at www.streamlinehealth.net.
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995
Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements included herein. Forward-looking statements contained in this press release include, without limitation, statements regarding the Company's estimates of future revenue, backlog, results of investments in sales and marketing, success of future products and related expectations and assumptions. These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive solutions and pricing, solution demand and market acceptance, new solution development and enhancement of current solutions, key strategic alliances with vendors and channel partners that resell the Company's solutions, the ability of the Company to control costs, availability of solutions from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accounting Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry generally and the markets in which the Company operates and nationally, and the Company's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.
Company Contact:
Randy Salisbury
SVP, Chief Marketing Officer
(404) 229-4242
randy.salisbury@streamlinehealth.net
STREAMLINE HEALTH SOLUTIONS, INC. | ||||||
Three Months Ended April 30, | ||||||
2018 | 2017 | |||||
Revenues: | ||||||
Systems sales | $ | 1,131,674 | $ | 378,723 | ||
Professional services | 238,314 | 420,035 | ||||
Audit Services | 359,713 | 345,019 | ||||
Maintenance and support | 3,309,104 | 3,354,772 | ||||
Software as a service | 1,224,368 | 1,425,132 | ||||
Total revenues | 6,263,173 | 5,923,681 | ||||
Operating expenses: | ||||||
Cost of systems sales | 249,984 | 566,051 | ||||
Cost of professional services | 706,230 | 715,215 | ||||
Cost of audit services | 393,979 | 440,639 | ||||
Cost of maintenance and support | 648,339 | 806,522 | ||||
Cost of software as a service | 316,387 | 339,376 | ||||
Selling, general and administrative | 3,249,057 | 3,373,528 | ||||
Research and development | 1,062,319 | 1,556,938 | ||||
Total operating expenses | 6,626,295 | 7,798,259 | ||||
Operating loss | (363,122) | (1,874,588) | ||||
Other income (expense): | ||||||
Interest expense | (116,218) | (127,268) | ||||
Miscellaneous income (expenses) | (87,645) | (38,044) | ||||
Loss before income taxes | (566,985) | (2,039,900) | ||||
Income tax benefit (expense) | (1,714) | (2,608) | ||||
Net Income (Loss) | $ | (568,699) | $ | (2,042,508) | ||
Net loss per common share – basic and diluted | $ | (0.03) | $ | (0.10) | ||
Weighted average number of common shares – basic and diluted | 19,986,425 | 19,695,390 | ||||
STREAMLINE HEALTH SOLUTIONS, INC.
Assets | ||||
April 30, | January 31, | |||
2018 | 2018 | |||
Current assets: | ||||
Cash and cash equivalents | $ | 3,745,532 | $ | 4,619,834 |
Accounts receivable, net of allowance for doubtful | 2,819,849 | 3,001,170 | ||
Contract receivables | 923,274 | 223,791 | ||
Prepaid hardware and third-party software for future delivery | -- | 5,858 | ||
Prepaid client maintenance contracts | 555,689 | 506,911 | ||
Other prepaid assets | 608,363 | 742,232 | ||
Other current assets | 545,431 | 546,885 | ||
Total current assets | 9,198,138 | 9,646,681 | ||
Non-current assets: | ||||
Property and equipment: | ||||
Computer equipment | 2,831,024 | 2,852,776 | ||
Computer software | 730,950 | 730,950 | ||
Office furniture, fixtures and equipment | 683,443 | 683,443 | ||
Leasehold improvements | 729,348 | 729,348 | ||
4,974,765 | 4,996,517 | |||
Accumulated depreciation and amortization | (3,981,311) | (3,834,153) | ||
Property and equipment, net | 993,454 | 1,162,364 | ||
Contract Receivables, less current portion | 686,658 | -- | ||
Capitalized software development costs, net of | 4,717,986 | 4,307,351 | ||
Intangible assets, net | 5,600,204 | 5,835,151 | ||
Goodwill | 15,537,281 | 15,537,281 | ||
Other non-current assets | 577,570 | 642,226 | ||
Total non-current assets | 28,113,153 | 27,484,373 | ||
$ | 37,311,291 | $ | 37,131,054 | |
STREAMLINE HEALTH SOLUTIONS, INC.
Liabilities and Stockholders' Equity | ||||
April 30, | January 31, | |||
2018 | 2018 | |||
Current liabilities: | ||||
Accounts payable | $ | 1,344,377 | $ | 421,425 |
Accrued compensation | 829,062 | 342,351 | ||
Accrued other expenses | 766,353 | 609,582 | ||
Current portion of long-term debt | 596,984 | 596,984 | ||
Deferred revenues | 7,301,408 | 9,481,807 | ||
Total current liabilities | 10,838,184 | 11,452,149 | ||
Non-current liabilities: | ||||
Term loan, net of deferred financing cost of $110,541 and $128,275, respectively | 3,769,840 | 3,901,353 | ||
Royalty liability | 2,518,068 | 2,469,193 | ||
Lease incentive liability, less current portion | 254,933 | 274,128 | ||
Deferred revenues, less current portion | 181,877 | 332,645 | ||
Total non-current liabilities | 6,724,718 | 6,977,319 | ||
Total liabilities | 17,562,902 | 18,429,468 | ||
Series A 0% Convertible Redeemable Preferred Stock, $.01 par value per share, $8,849,985 redemption and liquidation value, 4,000,000 shares authorized, 2,895,464 and 2,949,995 issued and outstanding, respectively, net of unamortized preferred stock discount of $0 | 8,686,392 | 8,849,985 | ||
Stockholders' equity: | ||||
Common stock, $.01 par value per share, 45,000,000 shares authorized; 20,034,446 and 20,005,977 shares issued and outstanding, respectively | 200,344 | 200,060 | ||
Additional paid in capital | 82,115,469 | 81,776,606 | ||
Accumulated deficit | (71,253,816) | (72,125,065) | ||
Total stockholders' equity | 11,061,997 | 9,851,601 | ||
$ | 37,311,291 | $ | 37,131,054 | |
STREAMLINE HEALTH SOLUTIONS, INC. | ||||||
Three Months Ended, | ||||||
April 30, 2018 | April 30, 2017 | |||||
Operating activities: | ||||||
Net loss | $ | (568,699) | $ | (2,042,508) | ||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities, net of acquisitions: | ||||||
Depreciation | 171,215 | 202,782 | ||||
Amortization of capitalized software development costs | 315,412 | 571,428 | ||||
Amortization of intangible assets | 234,947 | 333,057 | ||||
Amortization of other deferred costs | 119,910 | 100,815 | ||||
Valuation adjustment for warrants liability | -- | (31,210) | ||||
Share-based compensation expense | 222,458 | 267,174 | ||||
Other valuation adjustments | 51,142 | 48,467 | ||||
Loss (Gain) on disposal of fixed assets | (1,555) | (720) | ||||
Provision for accounts receivable | (7,851) | 187,134 | ||||
Changes in assets and liabilities, net of assets acquired: | ||||||
Accounts and contract receivables | (446,246) | 618,647 | ||||
Other assets | 43,207 | (97,889) | ||||
Accounts payable | 922,952 | (240,403) | ||||
Accrued expenses | 622,020 | 382,530 | ||||
Deferred revenues | (1,641,942) | (1,754,243) | ||||
Net cash provided by (used in) operating activities | 36,970 | (1,454,942) | ||||
Investing activities: | ||||||
Purchases of property and equipment | (3,300) | (8,719) | ||||
Proceeds from sales of property and equipment | 14,225 | -- | ||||
Capitalization of software development costs | (726,047) | (386,498) | ||||
Net cash used in investing activities | (715,122) | (395,217) | ||||
Financing activities: | ||||||
Principal repayments on term loan | (149,246) | (163,951) | ||||
Principal payments on capital lease obligations | -- | (33,811) | ||||
Payments related to settlement of employee share-based awards | (46,904) | (28,927) | ||||
Net cash used in financing activities | (196,150) | (226,689) | ||||
Increase (decrease) in cash and cash equivalents | (874,302) | (2,076,848) | ||||
Cash and cash equivalents at beginning of year | 4,619,834 | 5,654,093 | ||||
Cash and cash equivalents at end of year | $ | 3,745,532 | $ | 3,577,245 | ||
STREAMLINE HEALTH SOLUTIONS, INC.
Table A | ||||||
April 30, | January 31, | April 30, | ||||
Streamline Health Software Licenses | $ | 115,000 | $ | 984, 000 | $ | 11,234,000 |
Hardware and Third Party Software | -- | -- | 100,000 | |||
Professional Services | 2,415,000 | 2,048,000 | 3,642,000 | |||
Audit Services | 703,000 | 1,293,000 | 1,634,000 | |||
Maintenance and Support | 12,978,000 | 15,420,000 | 18,084,000 | |||
Software as a Service | 9,903,000 | 13,048,000 | 13,194,000 | |||
Total | $ | 26,114,000 | $ | 32,793,000 | $ | 47,888,000 |
STREAMLINE HEALTH SOLUTIONS, INC.
Table B | ||||
Three Months Ended | ||||
April 30, 2018 | ||||
Value | % of Total Bookings | |||
Streamline Health Software licenses | $ | 1,147,000 | 33% | |
Software as a service | 398,000 | 12% | ||
Maintenance and support | 713,000 | 21% | ||
Professional services | 1,118,000 | 33% | ||
Audit Services | 58,000 | 2% | ||
Total bookings | $ | 3,434,000 | 100% | |
Reconciliation of Non-GAAP Financial Measures |
(Unaudited)
|
Table C |
This press release contains a non-GAAP financial measure under the rules of the U.S. Securities and Exchange Commission for Adjusted EBITDA. This non-GAAP information supplements and is not intended to represent a measure of performance in accordance with disclosures required by generally accepted accounting principles. Non-GAAP financial measures are used internally to manage the business, such as in establishing an annual operating budget. Streamline Health's management in its operating and financial decision-making uses non-GAAP financial measures because management believes these measures reflect ongoing business in a manner that allows meaningful period-to-period comparisons. Accordingly, the Company believes it is useful for investors and others to review both GAAP and non-GAAP measures in order to (a) understand and evaluate current operating performance and future prospects in the same manner as management does and (b) compare in a consistent manner the Company's current financial results with past financial results. The primary limitations associated with the use of non-GAAP financial measures are that these measures may not be directly comparable to the amounts reported by other companies and they do not include all items of income and expense that affect operations. The Company's management compensates for these limitations by considering the Company's financial results and outlook as determined in accordance with GAAP and by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures in the tables attached to this press release. Streamline Health defines "Adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, professional and advisory fees, and internal direct costs incurred to complete transactions. |
Reconciliation of net earnings (loss) to non-GAAP Adjusted EBITDA (in thousands):
(Unaudited) | ||||
Adjusted EBITDA Reconciliation | Three Months Ended, | |||
April 30, 2018 | April 30, 2017 | |||
Net loss | $ | (569) | $ | (2,043) |
Interest expense | 116 | 127 | ||
Income tax benefit | 2 | 3 | ||
Depreciation | 171 | 203 | ||
Amortization of capitalized software development costs | 315 | 571 | ||
Amortization of intangible assets | 235 | 333 | ||
Amortization of other costs | 102 | 89 | ||
EBITDA | 372 | (722) | ||
Share-based compensation expense | 222 | 267 | ||
Loss on disposal of fixed assets | (2) | (1) | ||
Non-cash valuation adjustments to assets and liabilities | 51 | 17 | ||
Adjusted EBITDA | $ | 643 | $ | (439) |
Adjusted EBITDA per diluted share | ||||
Loss per share – diluted | $ | (0.03) | $ | (0.10) |
Adjusted EBITDA per adjusted diluted share (1) | $ | 0.03 | $ | (0.02) |
Diluted weighted average shares | 19,986,425 | 19,695,390 | ||
Includable incremental shares — Adjusted EBITDA (2) | 3,075,198 | -- | ||
Adjusted diluted shares | 23,061,622 | 19,695,390 | ||
(1) | Adjusted EBITDA per adjusted diluted share for the Company's common stock is computed using the more dilutive of the two-class method or the if-converted method. |
(2) | The number of incremental shares that would be dilutive under profit assumption, only applicable under a GAAP net loss. If GAAP profit is earned in the current period, no additional incremental shares are assumed. |
View original content with multimedia:http://www.prnewswire.com/news-releases/streamline-health-reports-first-quarter-2018-financial-performance-300661184.html
SOURCE Streamline Health Solutions, Inc.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Streamline Health Solutions IncShsmehr Nachrichten
|
10.09.24 |
Ausblick: Streamline Health Solutions legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) |
Analysen zu Streamline Health Solutions IncShsmehr Analysen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.